{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:04:17Z","timestamp":1789679057975,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012912","name":"Imperial College Healthcare Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015250","name":"NIHR Bristol Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015250","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000313","name":"British Society for Antimicrobial Chemotherapy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["215275\/Z\/19\/Z"],"award-info":[{"award-number":["215275\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT096382AIA"],"award-info":[{"award-number":["WT096382AIA"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jaci.2020.09.034","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T23:15:56Z","timestamp":1602717356000},"page":"510-519.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"title":["Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon"],"prefix":"10.1016","volume":"147","author":[{"given":"Lydia J.","family":"Finney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Glanville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Farne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Aniscenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fenwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel V.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Belen","family":"Trujillo-Torralbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Ling","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Adelaide","family":"Calderazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadwiga A.","family":"Wedzicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Mallia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan W.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian L.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9849-0033","authenticated-orcid":false,"given":"Aran","family":"Singanayagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2020.09.034_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1741-7015-10-27","article-title":"Viruses exacerbating chronic pulmonary disease: the role of immune modulation","volume":"10","author":"Singanayagam","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.jaci.2020.09.034_bib3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S2213-2600(20)30167-3","article-title":"Do chronic respiratory diseases or their treatment affect the risk of SARS-COV-2 infection?","volume":"8","author":"Halpin","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2020.09.034_bib4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2020.09.034_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233147","article-title":"Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis","volume":"15","author":"Alqahtani","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2020.09.034_bib6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.09.034_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/rccm.200707-973OC","article-title":"The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol\/fluticasone propionate or tiotropium bromide","volume":"177","author":"Wedzicha","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.09.034_bib8","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/s41467-018-04574-1","article-title":"Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations","volume":"9","author":"Singanayagam","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2020.09.034_bib9","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1038\/srep07176","article-title":"Glucocorticosteroids enhance replication of respiratory viruses: effect of adjuvant interferon","volume":"4","author":"Thomas","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2020.09.034_bib10","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/infdis\/jix167","article-title":"Human metapneumovirus infection in chronic obstructive pulmonary disease: impact of glucocorticosteroids and interferon","volume":"215","author":"Kan","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2020.09.034_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.resinv.2019.12.005","article-title":"Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells","volume":"58","author":"Yamaya","year":"2020","journal-title":"Respir Investig"},{"key":"10.1016\/j.jaci.2020.09.034_bib12","doi-asserted-by":"crossref","unstructured":"Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W, et\u00a0al. The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15 [e-pub ahead of print]. BioRxiv doi: https:\/\/doi.org\/10.1101\/2020.03.11.987016. Accessed July 7, 2020.","DOI":"10.1101\/2020.03.11.987016"},{"key":"10.1016\/j.jaci.2020.09.034_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2020.09.034_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00688-2020","article-title":"ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19","volume":"55","author":"Leung","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2020.09.034_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaci.2020.04.009","article-title":"Association of respiratory allergy, asthma and expression of the SARS-CoV-2 receptor, ACE2","volume":"146","author":"Jackson","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.09.034_bib16","doi-asserted-by":"crossref","unstructured":"Sajuthi SP, DeFord P, Jackson ND, Montgomery MT, Everard JL, Rios CL, et\u00a0al. Type 2 and interferon inflammation strongly regulate SARS-CoV-2 related gene expression in the airway epithelium [e-pub ahead of print]. Biorxiv doi:https:\/\/doi.org\/10.1101\/2020.04.09.034454. Accessed July 7, 2020.","DOI":"10.1038\/s41467-020-18781-2"},{"key":"10.1016\/j.jaci.2020.09.034_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1164\/rccm.202003-0821OC","article-title":"COVID-19 related genes in sputum cells in asthma: relationship to demographic features and corticosteroids","volume":"202","author":"Peters","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.09.034_bib18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2020.09.034_bib19","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2020.09.034_bib20","doi-asserted-by":"crossref","first-page":"L893","DOI":"10.1152\/ajplung.00253.2019","article-title":"Antiviral immunity is impaired in COPD patients with frequent exacerbations","volume":"317","author":"Singanayagam","year":"2019","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jaci.2020.09.034_bib21","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jaci.2017.10.017","article-title":"Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease","volume":"142","author":"Mallia","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.09.034_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav3879","article-title":"Inhaled corticosteroid suppression of cathelicidin drives dysbiosis and bacterial infection in chronic obstructive pulmonary disease","volume":"11","author":"Singanayagam","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2020.09.034_bib23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.chest.2020.05.531","article-title":"Beclomethasone has lesser suppressive effects on inflammation and anti-bacterial immunity than fluticasone or budesonide in experimental infection models","volume":"158","author":"Kamal","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2020.09.034_bib24","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 [e-pub ahead of print]","author":"Hoffman","year":"2020","journal-title":"BiorXiv"},{"key":"10.1016\/j.jaci.2020.09.034_bib25","doi-asserted-by":"crossref","unstructured":"Wang K, Chen W, Zhou Y, Lian J, Zheng Z, Du P, et\u00a0al. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein [e-pub ahead of print]. BioRxiv doi: https:\/\/doi.org\/10.1101\/2020.03.14.988345. Accessed July 7, 2020.","DOI":"10.1101\/2020.03.14.988345"},{"key":"10.1016\/j.jaci.2020.09.034_bib26","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is enriched in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2020.09.034_bib27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1042\/CS20140654","article-title":"A short-term mouse model that reproduces the immunopathological features of rhinovirus-induced exacerbation of COPD","volume":"129","author":"Singanayagam","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jaci.2020.09.034_bib28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2020.09.034_bib29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2020.09.034_bib30","doi-asserted-by":"crossref","first-page":"14614","DOI":"10.1128\/JVI.79.23.14614-14621.2005","article-title":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia","volume":"79","author":"Jia","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.jaci.2020.09.034_bib31","first-page":"450","article-title":"Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection","volume":"57","author":"Yang","year":"2007","journal-title":"Comp Med"},{"key":"10.1016\/j.jaci.2020.09.034_bib32","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2020.09.034_bib33","doi-asserted-by":"crossref","unstructured":"Lukassen S, Chua RL, Trefzer T, Kahn NC, Schneider M, Muley T, et\u00a0al. SARS-CoV-2 receptor ACE2 and TMPRSS2 are predominantly expressed in a transient secretory cell type in subsegmental bronchial branches [e-pub ahead of print]. BioRxiv doi: https:\/\/doi.org\/10.1101\/2020.03.13.991455. Accessed July 7, 2020.","DOI":"10.1101\/2020.03.13.991455"},{"key":"10.1016\/j.jaci.2020.09.034_bib34","article-title":"Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells [e-pub ahead of print]","author":"Muus","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.jaci.2020.09.034_bib35","doi-asserted-by":"crossref","first-page":"454","DOI":"10.7150\/ijbs.13379","article-title":"Alternative roles of STAT3 and MAPK signaling pathways in the MMPs activation and progression of lung injury induced by cigarette smoke exposure in ACE2 knockout mice","volume":"12","author":"Hung","year":"2016","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jaci.2020.09.034_bib36","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.09.034_bib37","doi-asserted-by":"crossref","first-page":"2000547","DOI":"10.1183\/13993003.00547-2020","article-title":"Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis","volume":"55","author":"Guan","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2020.09.034_bib38","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2020.09.034_bib40","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1399-3038.2004.00137.x","article-title":"Childhood severe acute respiratory syndrome, coronavirus infections and asthma","volume":"15","author":"Van Bever","year":"2004","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2020.09.034_bib41","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1001\/jama.289.21.JOC30885","article-title":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area","volume":"289","author":"Booth","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2020.09.034_bib42","doi-asserted-by":"crossref","first-page":"m1985","DOI":"10.1136\/bmj.m1985","article-title":"Features of 20 133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study","volume":"369","author":"Docherty","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jaci.2020.09.034_bib43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2020.09.034_bib44","doi-asserted-by":"crossref","first-page":"L17","DOI":"10.1152\/ajplung.00498.2016","article-title":"Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg(9) bradykinin\/BKB1R axis and facilitates LPS-induced neutrophil infiltration","volume":"314","author":"Sodhi","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jaci.2020.09.034_bib45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.atherosclerosis.2006.10.013","article-title":"Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice","volume":"194","author":"Recinos","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jaci.2020.09.034_bib46","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(20)30691-7","article-title":"Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?","volume":"395","author":"Ritchie","year":"2020","journal-title":"Lancet"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492031407X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492031407X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:25:52Z","timestamp":1789676752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009167492031407X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S009167492031407X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2020.09.034","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.13.149039","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2020.09.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}